Onconetix (ONCO) EPS (Basic) Growth (3y) (2024 - 2026)
Onconetix (ONCO) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | -38.31% |
| 10 | Onconetix | 1.44 Mn | -4.51 Mn | 4,303.00 | 91.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.40% |
| Mar 31, 2026 | 86.97% |
| Dec 31, 2025 | 26.13% |
| Sep 30, 2025 | 81.07% |
| Jun 30, 2025 | 84.18% |
| Mar 31, 2025 | 66.14% |
| Dec 31, 2024 | 13.93% |
| Sep 30, 2024 | 43.05% |
| Jun 30, 2024 | -30.60% |